메뉴 건너뛰기




Volumn 58, Issue 2, 2005, Pages 171-174

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis

Author keywords

Automated databases; Fibrates; Myopathy; Positive predictive value; Rhabdomyolysis; Statins

Indexed keywords

ACUTE KIDNEY FAILURE; DATA BASE; GEOGRAPHY; HEALTH CARE PLANNING; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; MANAGED CARE; MYOPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RHABDOMYOLYSIS;

EID: 19944432924     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2004.10.004     Document Type: Article
Times cited : (42)

References (7)
  • 1
    • 0037414218 scopus 로고    scopus 로고
    • Statin-associated myopathy
    • P.D. Thompson, P. Clarkson, and R.H. Kara Statin-associated myopathy JAMA 289 2003 1681 1690
    • (2003) JAMA , vol.289 , pp. 1681-1690
    • Thompson, P.D.1    Clarkson, P.2    Kara, R.H.3
  • 2
    • 0036838982 scopus 로고    scopus 로고
    • Lipid-lowering agents and myopathy
    • R.L. Wormann Lipid-lowering agents and myopathy Curr Opin Rheumatol 14 2002 643 647
    • (2002) Curr Opin Rheumatol , vol.14 , pp. 643-647
    • Wormann, R.L.1
  • 4
    • 0037075262 scopus 로고    scopus 로고
    • Cerivastatin and reports of fatal rhabdomyolysis
    • J.A. Staffa, J. Chang, and L. Green Cerivastatin and reports of fatal rhabdomyolysis N Engl J Med 346 2002 539 540
    • (2002) N Engl J Med , vol.346 , pp. 539-540
    • Staffa, J.A.1    Chang, J.2    Green, L.3
  • 5
    • 0034046256 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors and myotoxicity
    • M. Ucar, T. Mjorndal, and R. Dahlqvist HMG-CoA reductase inhibitors and myotoxicity Drug Safety 22 2000 441 457
    • (2000) Drug Safety , vol.22 , pp. 441-457
    • Ucar, M.1    Mjorndal, T.2    Dahlqvist, R.3
  • 6
    • 0034887738 scopus 로고    scopus 로고
    • Lipid-lowering drugs and risk of myopathy: A population-based follow-up study
    • D. Gaist, L.A. Rodriguez, C. Huerta, J. Hallas, and S.H. Sindrup Lipid-lowering drugs and risk of myopathy: a population-based follow-up study Epidemiology 12 2001 565 569
    • (2001) Epidemiology , vol.12 , pp. 565-569
    • Gaist, D.1    Rodriguez, L.A.2    Huerta, C.3    Hallas, J.4    Sindrup, S.H.5
  • 7
    • 0036894223 scopus 로고    scopus 로고
    • Etiology and frequency of rhabdomyolysis
    • C. Black, and H. Jick Etiology and frequency of rhabdomyolysis Pharmacotherapy 22 2002 1524 1526
    • (2002) Pharmacotherapy , vol.22 , pp. 1524-1526
    • Black, C.1    Jick, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.